Table 1.
Top 10 ATC second- and third-level drug code groups ranked in 2009 and 2013 according to value-based turnover of dispensed medicines and its growth ratio 2013/2009a.
| Top 10 ATC second-level code groups in 2009and 2013 (hierarchy from 2009 appliedin descending order of appearance) | Value of prescriptions dispensed in 2009 (million €) | Value of prescriptions dispensed in 2013 (million €) | Growth ratio 2013/2009 | Total increase 2009–2013 (million €) |
|---|---|---|---|---|
| C09 agents acting on the renin–angiotensin system | 25.9 | 26.8 | 1.03 | 0.9 |
| J01 antibacterials for systemic use | 21.8 | 16.2 | 0.74 | 5.6 |
| L01 antineoplastic agents | 16.1 | 21.4 | 1.33 | 5.3 |
| N05 psycholeptics | 13 | 10.1 | 0.78 | 2.9 |
| A10 drugs used in diabetes | 12.5 | 23.1 | 1.85 | 10.6 |
| A02 drugs for acid-related disorders | 10.5 | 10.3 | 0.98 | 0.2 |
| N02 analgesics | 9.6 | 9.1 | 0.95 | 0.5 |
| C08 calcium channel blockers | 7.4 | 5.4 | 0.73 | 2 |
| M01 anti-inflammatory and antirheumatic products | 7.4 | 8.9 | 1.21 | 1.5 |
| C07 beta blocking agent | 6.9 | 8.1 | 1.18 | 1.2 |
| B01 antithrombotic agents | 6.8 | 10.6 | 1.56 | 3.8 |
| Top 10 ATC third-level code groups according to 2013/2009 growth ratio | Value of prescriptions dispensed in 2009 (thousand €) | Value of prescriptions dispensed in 2013 (thousand €) | Growth ratio 2013/2009 | Total increase 2009–2013 (thousand €) |
| C01C cardiac stimulants excluding cardiac glycosides | 7.6 | 122 | 16.07 | 114.5 |
| S03A anti-infectives | 3.8 | 36 | 9.47 | 32.2 |
| M03A muscle relaxants, peripherally acting agents | 37.1 | 347.6 | 9.37 | 310.5 |
| C09D angiotensin II antagonists, combinations | 511 | 2993.1 | 5.86 | 2482.1 |
| S01B Anti-inflammatory agents | 17.8 | 99.5 | 5.59 | 81.7 |
| R01B nasal decongestants for systemic use | 484.6 | 2350.1 | 4.85 | 1865.5 |
| D03A cicatrizants | 43.3 | 169 | 3.90 | 125.7 |
| L01A alkylating agents | 238.6 | 876.8 | 3.67 | 638.2 |
| V03A all other therapeutic products | 53 | 189.2 | 3.57 | 136.2 |
| G02B contraceptives for topical use | 19.9 | 70.5 | 3.54 | 50.6 |
aLatest Republic of Srpska’s official release available [publicly reimbursed prescription medicines only; over-the-counter (OTC) and out-of-pocket citizen payments excluded].